98%
921
2 minutes
20
Aim: Drug overdose related-deaths in the US are increasing, with over 100,000 deaths occurring in 2020, an increase of 30% from the previous year and the highest number recorded in a single year. It is widely known that experiences of trauma and substance use very often co-occur, but little is known about the role of trauma in the context of drug overdose-related deaths. Latent class analysis (LCA) was used to classify drug overdose-related deaths based on type of traumatic experiences and individual, social, and substance use characteristics.
Methods: Psychological autopsy data were obtained from the University of Texas Health Science Center at Houston (UTHealth) Brain Collection. A total of 31 drug overdose-related deaths collected from January 2016 through March 2022 were included in this study. LCA was used to identify latent factors via experience of four trauma categories (illness/accidents, sexual/interpersonal violence, death/trauma to another, other situations where life was in danger). Generalized linear modeling (GLM) was used to explore differences on demographic, social, substance use, and psychiatric variables between the latent classes in separate models.
Results: LCA identified 2 classes: C1 ( =12; 39%) was characterized by higher incidence of overall trauma exposure as well as variation in trauma type; C2 ( =19; 61%) had lower levels of overall trauma exposure with sexual/interpersonal violence as the most frequent. GLMs indicated that C1 membership was associated with higher incidence of polysubstance use, being married, and having suicidal ideation compared to C2 membership ( s<0.05).
Conclusion: Among individuals who died by drug overdose, the exploratory LCA identified two distinct subgroups that differed in type of trauma experienced and substance use pattern, the first group having more "typical" characteristics of drug overdoses cases, the other group less typical. This suggests that those at risk of drug overdose may not always exhibit high-risk characteristics.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187323 | PMC |
http://dx.doi.org/10.1101/2023.04.30.23289256 | DOI Listing |
Unlabelled: Policy Points Among patients with chronic noncancer pain, state medical cannabis laws did not impact health care use for opioid use disorder. There were no changes in health care use for opioid overdose attributable to medical cannabis laws. Medical cannabis laws do not appear to lead to reductions in adverse opioid-related outcomes.
View Article and Find Full Text PDFJAMA Netw Open
August 2025
Center for Addiction Medicine, Denver Health and Hospital Authority, Denver, Colorado.
Importance: In opioid treatment programs (OTPs), restarting methadone after missed doses is common. Current guidelines recommend significant dose decreases but do not account for maintained tolerance.
Objective: To evaluate the safety and treatment retention associated with a novel methadone restart protocol.
Clin Toxicol (Phila)
August 2025
Department of Chemistry, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
Background: Overdoses involving antidepressant and cardiovascular drugs account for 21.9% of non-opioid overdose-related fatalities in the United States. Activated charcoal is commonly used for gastrointestinal decontamination, but data regarding its adsorption efficacy for several clinically relevant drugs remain limited.
View Article and Find Full Text PDFJ Med Internet Res
August 2025
Department of Emergency and Disaster Medical Pharmacy, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1, Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan, 81 928716631.
Subst Use Addctn J
July 2025
Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Background: Mobile health (mHealth) applications are positioned to provide information and support anywhere and anytime, though few focus on overdose-related harm reduction. We aimed to describe the use of an e-harm reduction smartphone application theoretically based on self-determination theory among people who inject drugs.
Methods: We enrolled 60 clients from 3 syringe services programs in Wisconsin in a single-arm, pre-post pilot study between December 2022 and June 2023.